The global immune BCG market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). BCG (stands for Bacille Calmette-Guérin) is the most widely used tuberculosis vaccine only currently available for being commercialized for the prevention of tuberculosis. This vaccine is generally administered to children at birth in countries with high incidence of tuberculosis. However, in low incidence regions, only children at high risk are typically immunized, whereas, adults are generally not immunized. However, adults (up to the age of 35) who are frequently exposed to drug-resistant tuberculosis may also be given BCG vaccine. The market growth is driven by a surge in the prevalence of tuberculosis coupled with the growth in the technological advancements for vaccine research. Moreover, rising government initiatives and emphasis on immunization programs all over the globe, also boost the market growth. 

 Various advancements in the areas of mycobacterial immunology and genomics have fueled the research on multiple new experimental vaccines. This is further likely to offer futuristic opportunities for the market growth. In addition to this, the relatively low cost of these vaccines, along with the added high safety, low side effects, as well as the easy availability of the vaccine are the major drivers of the market growth. Furthermore, untapped market potential in developing regions is expected to provide lucrative opportunities for the market growth. Although, the vague responses of the BCG vaccine on immunity and a global shortage of the vaccine might act as a hindrance to the market growth. 

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Type

o By Application

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape:  Merck & Co., Inc., and InterVax Ltd., among others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How are players addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Immune BCG Market Report by Segment

By Type

    • 0.5ml Package

    • 1ml Package

    • 2ml Package

    • Others

By Application

    • Hospitals

    • Clinics

Global Immune BCG Market Report by Region

North America       

    • US

    • Canada

Europe

    • Germany

    • UK

    • France

    • Spain

    • Italy

    • Rest of Europe

Asia-Pacific    

    • China

    • Japan

    • India

    • Rest of Asia-Pacific

Rest of the World

    • Latin America

    • Middle East and Africa